Table on assessment times for parallel import
Updated 18 March 2025
| Table 1. Average assessment times for parallel import | ||||||
| Average assessment time | Target days | Difference between assessment time and target days | No. of cases measured No. of Drug IDs | No. of cases within target | Share of cases within target in percent | |
| Parallel import | ||||||
| 1st quarter 2023 | 153 | 60 | 93 | 213 | 101 | 47 |
| 2nd quarter 2023 | 123 | 60 | 63 | 99 | 67 | 68 |
| 3rd quarter 2023 | 49 | 60 | -11 | 168 | 145 | 86 |
| 4th quarter 2023 | 73 | 60 | 13 | 150 | 123 | 82 |
| 1st quarter 2024 | 61 | 60 | 1 | 135 | 118 | 87 |
| 2nd quarter 2024 | 58 | 60 | -2 | 118 | 96 | 81 |
| 3rd quarter 2024 | 75 | 60 | 15 | 119 | 97 | 82 |
| 4th quarter 2024 | 81 | 60 | 21 | 181 | 153 | 85 |
| Table 2. Average assessment times for parallel import – Human medicines | ||||||
| Average assessment time | Target days | Difference between assessment time and target days | No. of cases measured No. of Drug IDs | No. of cases within target | Share of cases within target in percent | |
| Parallel import | ||||||
| 1st quarter 2023 | 151 | 60 | 91 | 207 | 99 | 48 |
| 2nd quarter 2023 | 123 | 60 | 63 | 99 | 67 | 68 |
| 3rd quarter 2023 | 48 | 60 | -12 | 166 | 145 | 87 |
| 4th quarter 2023 | 73 | 60 | 13 | 146 | 121 | 83 |
| 1st quarter 2024 | 58 | 60 | -2 | 130 | 115 | 88 |
| 2nd quarter 2024 | 58 | 60 | -2 | 118 | 96 | 81 |
| 3rd quarter 2024 | 75 | 60 | 15 | 118 | 97 | 82 |
| 4th quarter 2024 | 67 | 60 | 7 | 173 | 153 | 88 |
| Table 3. Average assessment times for parallel import – Veterinary medicines | ||||||
| Average assessment time | Target days | Difference between assessment time and target days | No. of cases measured No. of Drug IDs | No. of cases within target | Share of cases within target in percent | |
| Parallel import | ||||||
| 1st quarter 2023 | 237 | 60 | 177 | 6 | 2 | 33 |
| 2nd quarter 2023 | 60 | 0 | ||||
| 3rd quarter 2023 | 132 | 60 | 72 | 2 | 0 | 0 |
| 4th quarter 2023 | 100 | 60 | 40 | 4 | 2 | 50 |
| 1st quarter 2024 | 125 | 60 | 65 | 5 | 3 | 60 |
| 2nd quarter 2024 | 60 | 0 | ||||
| 3rd quarter 2024 | 132 | 60 | 72 | 1 | 0 | 0 |
| 4th quarter 2024 | 374 | 60 | 314 | 8 | 0 | 0 |